Proteome Systems has announced the release of its new bioinformatic analysis tools for glycomics. These tools will add value to the Company’s leading annotated database and search engine of glycoprotein derived glycan structures. The tools and database (to be marketed together as GlycoSuite) will enable researchers for the first time to easily identify the sugars on glycoproteins from data generated by mass spectrometers. Glycoproteins play a key role in a range of diseases, from viral infections to cancer. The GlycoSuite tools allow researchers to gain an enhanced understanding of the complexity of glycomics, resulting in a better knowledge of disease and the development of a new generation of drug therapies. In addition, the GlycoSuite tools will enable improved quality control monitoring of glycoprotein pharmaceutical products, such as erythropoietin (EPO).
